SCHEDULE 13G: Nantahala Capital Management Discloses 9.99% Stake in EDESA BIOTECH, INC.

Nantahala Capital Management, LLC, along with Wilmot B. Harkey and Daniel Mack, has disclosed a beneficial ownership of 9.99% in EDESA BIOTECH, INC. common shares.

Summary

• Nantahala Capital Management, LLC, Wilmot B. Harkey, and Daniel Mack (collectively, the "Reporting Persons") have filed a Schedule 13G, indicating beneficial ownership in EDESA BIOTECH, INC.
• As of March 31, 2025, the Reporting Persons collectively beneficially own 700,488 common shares of EDESA BIOTECH, INC.
• This aggregate amount represents 9.99% of the total outstanding common shares of EDESA BIOTECH, INC.
• The reported shares include 75,488 shares that can be acquired by the Reporting Persons within sixty days through the exercise of warrants.
• Nantahala Capital Management, LLC holds shared voting and shared dispositive power over all 700,488 shares.
• Wilmot B. Harkey and Daniel Mack, as managing members of Nantahala, also hold shared voting and shared dispositive power over the same 700,488 shares.
• The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
• BLACKWELL PARTNERS LLC SERIES A, a fund advised by Nantahala, has the right to receive dividends or proceeds from the sale of more than five percent of the beneficially owned shares.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or prospects. It is a neutral regulatory filing.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of a significant ownership stake by an investment firm in a biotechnology company. Such disclosures are common and provide transparency regarding institutional holdings, which can sometimes signal investor confidence or strategic interest in the sector.

Related Party Transactions

• BLACKWELL PARTNERS LLC SERIES A, a fund advised by Nantahala Capital Management, LLC, has the right to receive dividends or proceeds from the sale of more than five percent of the outstanding shares beneficially owned by Nantahala.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, which could influence market perception and trading activity.

Key Dates

Keywords

EDESA BIOTECH, Nantahala Capital Management, Beneficial Ownership, Schedule 13G, Common Shares, Investment Adviser, Biotechnology, Shareholding, Warrants